Patient Guide: Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 49 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04924101
Status: COMPLETED
Condition: Small Cell Lung Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 49 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Gilbert, Arizona
  • Aurora, Colorado
  • Atlanta, Georgia
  • • And 46 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily